“Expresión de PD-L1 e infiltración de linfocitos CD8+ como biomarcadores para la inmunoterapia
en el cáncer nasosinusal Page 1 Programa de Doctorado en Biomedicina y Oncología Molecular …

Patienten, bei denen ein Rhabdomyosarkom (RMS) festgestellt wird, sind mit einer
schlechten Prognose konfrontiert. Standardtherapien (Radiochemotherapie und …

Cancer was initially thought to be just a disease of cells with deregulated gene expression. It
may be more accurate to consider cancer as a disease of the microenvironment. Despite the …

Here we present the concept of making own patient's anti-cancer treatment more efficient
and starting at testing the efficacy of immunological system. The respective tests are …

Langerhans cell histiocytosis (LCH) is a neoplastic myeloid disorder with a thus far poorly
understood immune component. Tertiary lymphoid structures (TLS) are lymph node-like …

Le cancer de la vessie est le 5e plus répandu au Canada. Les tumeurs vésicales non-
infiltrant le muscle (TVNIM) représentent 70-75% des tumeurs au premier diagnostic. Après …

Fiziksel aktivitenin insan sağlığı ve yaşamsal refahı için önemi bilinmektedir. Boş
zamanlarda yapılan fiziksel aktivitelerin, genetik ve diğer ailesel faktörlerin katılmasıyla bile …

Prostate cancer (PCa) is a leading cause of cancer-related death in men worldwide, with an
estimated 33,000 deaths projected in the US in 2020. Although primary (localized) tumors …

Purpose: Current TNM staging system can't provide adequate information for prediction of
prognosis and chemotherapeutic benefits. To construct a classifier to predict prognosis and …

Background: Nivolumab is the first checkpoint inhibitor approved for the treatment of
Squamous (Sq) and non-Squamous (non-Sq) metastatic NSCLC in secondline setting …